[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341996-105":59,"doc-detail-341996-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","preclinical-pharmacology-of-patient-derived-extracellular-vesicles-for-the-intraoperative-imaging-of-tumors","Preclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumors","","Extracellular vesicles (EVs) derived from oncological patients show strong tumor-targeting capacity compared with EVs from healthy individuals. Building on prior work, the study develops a protocol to formulate indocyanine green (ICG) with patient-derived extracellular vesicles (PDEVs), enabling near-infrared intraoperative tumor margin visualization. The ONCOGREEN protocol integrates PDEV isolation, ICG loading, and reinfusion. In vivo studies define pharmacologic parameters, biodistribution kinetics, and toxicological safety, while autologous PDEV large-scale isolation and preservation are optimized for translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/preclinical-pharmacology-of-patient-derived-extracellular-vesicles-for-the-intraoperative-imaging-of-tumors/341996/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/preclinical-pharmacology-of-patient-derived-extracellular-vesicles-for-the-intraoperative-imaging-of-tumors/341996.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the ONCOGREEN protocol described in the study?","Question",{"text":112,"@type":113},"ONCOGREEN is a workflow that includes PDEV isolation, indocyanine green (ICG) loading, and reinfusion into the same patients for intraoperative tumor margin imaging.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were key pharmacological and safety parameters assessed?",{"text":117,"@type":113},"Key parameters were derived from in vivo mouse studies, including PDEVs-ICG pharmacological behavior, biodistribution kinetics, and potential treatment-related toxicological effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the suitability of autologous PDEVs for clinical use?",{"text":121,"@type":113},"The study reports an autologous plasmapheresis-based isolation approach that yields sufficient PDEVs, and a preservation strategy (lyophilization) that maintains functional integrity for later clinical application.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341996,1790555121,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Ivyspring  \nInternational Publisher  \nTheranostics  \n2024; 14(16): 6301-6318. doi: 10.7150/thno.98671  \nResearch Paper  \nPreclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumors  \nAlessandro Villa1, Daniela Crescenti1, Zemira De Mitri1, Elisabetta Crippa1, Silvia Rosa1, Nicoletta Rizzi3, Fereshteh Shojaei-Ghahrizjani1, Monica Rebecchi1, Simona Vincenti2, Francesca Selmin3, Electra Brunialti1, Nicolò Simonotti5, Marianna Maspero5, Michele Dei Cas1, Camilla Recordati4, Saverio Paltrinieri4, Alessia Giordano4, Rita Paroni1, Margherita Galassi6, Vito Ladisa6, Flavio Arienti6, Francesco Cilurzo3, Vincenzo Mazzaferro5,6, Paolo Ciana1􀀍  \n1. Department of Health Sciences, University of Milan, Milan, Italy.  \n2. Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland.  \n3. Department of Pharmaceutical Sciences, University of Milan, Milan, Italy.  \n4. Department of Veterinary Medicine and Animal Sciences, University of Milan, Milan, Italy.  \n5. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.  \n6. HPB Surgery and Liver Transplantation, Istituto Nazionale Tumori IRCCS Foundation (INT), Milan, Italy.  \n􀀍 Corresponding author: [Ciana P: paolo.ciana@unimi.it](Ciana P: paolo.ciana@unimi.it).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.05.20; Accepted: 2024.08.14; Published: 2024.09.30  \nAbstract  \nExtracellular vesicles (EVs) derived from the plasma of oncological patients exhibit significant tumor-targeting properties, unlike those from healthy individuals. We have previously shown the feasibility of formulating the near-infrared (NIR) fluorescent dye indocyanine green (ICG) with patient-derived extracellular vesicles (PDEVs) for selective delivery to neoplastic tissue. This staining protocol holds promise for clinical application in intraoperative tumor margin imaging, enabling precise neoplastic tissue resection. To this end, we propose the ONCOGREEN protocol, involving PDEV isolation, ICG loading, and reinfusion into the same patients.  \nMethods: By in vivo studies on mice, we outlined key pharmacological parameters of PDEVs-ICG for intraoperative tumor imaging, PDEV biodistribution kinetics, and potential treatment-related toxicological effects. Additionally, we established a plasmapheresis-based protocol for isolating autologous PDEVs, ensuring the necessary large-scale dosage for human treatment. A potentiallyophilization-based preservation method was also explored to facilitate the storage and transport of PDEVs.  \nResults: The study identified the effective dose of PDEVs-ICG necessary for clear intraoperative tumor margin imaging. The biodistribution kinetics of PDEVs showed favorable targeting to neoplastic tissues, without off-target distribution. Toxicological assessments revealed no significant adverse effects associated with the treatment. The plasmapheresis-based isolation protocol successfully yielded a sufficient quantity of autologous PDEVs, and the lyophilization preservation method maintained the functional integrity of PDEVs for subsequent clinical application.  \nConclusions: Our research lays the groundwork for the direct clinical application of autologous PDEVs, initially focusing on intraoperative imaging. Utilizing autologous PDEVs has the potential to accelerate the integration of EVs as a targeted delivery tool for anti-neoplastic agents to cancerous tissue. This approach promises to enhance the precision of neoplastic tissue resection and improve overall surgical outcomes for oncological patients.  \nKeywords: EV Biodistribution Kinetics, Toxicology, Intraoperative Imaging, Bench-to-bedside Translation  \nIntroduct","cbCairuwEto1DyHM","https://ap.wps.com/l/cbCairuwEto1DyHM","pdf",2843542,18,"English","# Abstract\n# Methods\n## In vivo pharmacology and biodistribution\n## Autologous PDEV isolation and preservation\n# Results\n## Imaging dose and targeting\n## Toxicology and functional integrity\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the ONCOGREEN protocol described in the study?\",\"answer\":\"ONCOGREEN is a workflow that includes PDEV isolation, indocyanine green (ICG) loading, and reinfusion into the same patients for intraoperative tumor margin imaging.\"},{\"question\":\"How were key pharmacological and safety parameters assessed?\",\"answer\":\"Key parameters were derived from in vivo mouse studies, including PDEVs-ICG pharmacological behavior, biodistribution kinetics, and potential treatment-related toxicological effects.\"},{\"question\":\"What evidence supports the suitability of autologous PDEVs for clinical use?\",\"answer\":\"The study reports an autologous plasmapheresis-based isolation approach that yields sufficient PDEVs, and a preservation strategy (lyophilization) that maintains functional integrity for later clinical application.\"}]","Preclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumors | PDF",1790044678,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/329e8014f7bff938172bc25aedd093cd.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12b66a3f96cf8711f9842a123cc190b7.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ff1c597cc0051822962409c1ef1a192.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a07de619f5a14c845e5cb1242664764.webp",980,1268]